Aging
Navigate
Submit an Article
Research Paper|Volume 11, Issue 20|pp. 9043–9059
T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma
Back to articleFigure 3(3 of 7)
100%
Figure 3
Figure 3.Cellular viability of glioblastoma cells treated with T5224, Genipin and STO-609.
Figure 3 — T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma | Aging